Approval of Monotherapy for Advanced Breast Cancer by Cofepris.
blanca valadez Mexico City / 21.03.2023 18:43:56 The Federal Commission for the Protection against Sanitary Risks (Cofepris) approved the monotherapy developed in collaboration with Daiichi Sankyo, to care for people with HER2-positive and HER2-low advanced and metastatic breast cancer, who have received prior treatment, reported AstraZeneca Mexico. “With this innovative therapy, a new era begins … Read more